SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Magnetic Resonance Imaging Is Cost‐Effective for Hepatocellular Carcinoma Surveillance in High‐Risk Patients With Cirrhosis
8 references·0 citing·33 second hop
Magnetic Resonance Imaging Is Cost‐Effective for Hepatocellular Carcinoma Surveillance in High‐Risk Patients With Cirrhosis (2018)Magnetic Resonance Imaging Is Cost‐Effect…Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United States (2017)Early detection and curative …Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 (2016)Global, Regional, and Nationa…Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold (2014)Updating Cost-Effectiveness —…Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2014)Global, regional, and nationa…The NICE Cost-Effectiveness Threshold (2008)The NICE Cost-Effectiveness T…The Impact of Chronic Hepatitis B on Quality of Life: A Multinational Study of Utilities from Infected and Uninfected Persons (2008)The Impact of Chronic Hepatit…Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysis (2008)Surveillance of cirrhosis for…Screening for Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis: A Cost-Utility Analysis (2003)Screening for Hepatocellular …Markov Models in Medical Decision Making (1993)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)The green book : appraisal and evaluation in central government (2003)Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population (2012)The Markov Process in Medical Prognosis (1983)Methods for the economic evaluation of health care programmes (1987)The burden of illness associated with hepatocellular carcinoma in the United States (2008)Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis (2018)Theory of Games and Economic Behavior (1945)Theory of Games and Economic Behavior (1946)Cost-Effectiveness in Health and Medicine (1996)Utilities of the EQ-5D (2009)Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study (2010)Health utilities and psychometric quality of life in patients with early‐ and late‐stage hepatitis C virus infection (2011)XXIV. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. In a letter to Francis Baily, Esq. F. R. S. &c (1825)Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012)The State of US Health, 1990-2010 (2013)Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016)Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017)Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (2024)A convenient approximation of life expectancy (the “DEALE”) (1982)Cost‐effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C (2004)Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib for Patients With Unresectable or Metastatic Hepatocellular Carcinoma (2021)Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States (2020)The cost-effectiveness of digital health interventions: A systematic review of the literature (2022)Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research (2016)On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review (2018)Economics and mental health: the current scenario (2020)Measuring population ageing: an analysis of the Global Burden of Disease Study 2017 (2019)Mindfulness-Based Cognitive Therapy for Psychological Distress, Fear of Cancer Recurrence, Fatigue, Spiritual Well-Being, and Quality of Life in Patients With Breast Cancer—A Randomized Controlled Trial (2020)Population ageing and mortality during 1990–2017: A global decomposition analysis (2020)
this work references cited by second hop

References

  • 2014Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 20137,435 cited
  • 2016Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 20156,217 cited
  • 2014Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold2,247 cited
  • 2008The NICE Cost-Effectiveness Threshold868 cited
  • 2003Screening for Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis: A Cost-Utility Analysis252 cited
  • 2008The Impact of Chronic Hepatitis B on Quality of Life: A Multinational Study of Utilities from Infected and Uninfected Persons162 cited
  • 2017Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United States125 cited
  • 2008Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysis117 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work